Your browser doesn't support javascript.
loading
Cinobufagin inhibits tumor progression and reduces doxorubicin resistance by enhancing FOXO1-mediated transcription of FCGBP in osteosarcoma.
Ma, Xiucai; Suo, Zhigang; Ma, Xiaoyan; Zhan, Chunrui; Luo, Guodong; Song, Jianmin.
Afiliación
  • Ma X; Department of Bone and Soft Tissue Oncology, Gansu Provincial People's Hospital, Lanzhou, 730001, Gansu, PR China.
  • Suo Z; Department of Spinal Surgery, General Hospital of Ningxia Medical University, Yinchuan, 750004, Ningxia, PR China.
  • Ma X; Department of Plastic Surgery, Gansu Provincial People's Hospital, Lanzhou, 730001, Gansu, PR China.
  • Zhan C; Department of Bone and Soft Tissue Oncology, Gansu Provincial People's Hospital, Lanzhou, 730001, Gansu, PR China.
  • Luo G; Department of Bone and Soft Tissue Oncology, Gansu Provincial People's Hospital, Lanzhou, 730001, Gansu, PR China.
  • Song J; Department of Bone and Soft Tissue Oncology, Gansu Provincial People's Hospital, Lanzhou, 730001, Gansu, PR China. Electronic address: songjm1015@126.com.
J Ethnopharmacol ; 296: 115433, 2022 Oct 05.
Article en En | MEDLINE | ID: mdl-35690338

Texto completo: 1 Bases de datos: MEDLINE Medicinas Tradicionales: Medicinas_tradicionales_de_asia / Medicina_china Asunto principal: Neoplasias Óseas / Osteosarcoma Idioma: En Revista: J Ethnopharmacol Año: 2022 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Medicinas Tradicionales: Medicinas_tradicionales_de_asia / Medicina_china Asunto principal: Neoplasias Óseas / Osteosarcoma Idioma: En Revista: J Ethnopharmacol Año: 2022 Tipo del documento: Article